ACCORD-Lipid trial. First data on the impact of statin-fibrate combiínation on cardiovascular complications of diabetes

Abstract

AQn analysis of the results of the first large mortality trial of combination lipid lowering with statin-fibrate combination focused on the practical conseguences of these new data foor everyday clinical practise.

Keywords

• Type 2 diabetes mellitus
• statin
• fibrate
• triglycerides
• combination lipid therapy